HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia

por Komic, Hana, Hallner, Alexander, Hussein, Brwa Ali, Badami, Chiara, Wöhr, Anne, Hellstrand, Kristoffer, Bernson, Elin, Thorén, Fredrik B.
Publicado 2023

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia

por Hussein, Brwa Ali, Hallner, Alexander, Wennström, Lovisa, Brune, Mats, Martner, Anna, Hellstrand, Kristoffer, Bernson, Elin, Thorén, Fredrik B.
Publicado 2021

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia

por Hussein, Brwa Ali, Hallner, Alexander, Wennström, Lovisa, Brune, Mats, Martner, Anna, Hellstrand, Kristoffer, Bernson, Elin, Thorén, Fredrik B.
Publicado 2022

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells

por Hussein, Brwa Ali, Kristenson, Linnea, Pesce, Silvia, Wöhr, Anne, Tian, Yarong, Hallner, Alexander, Brune, Mats, Hellstrand, Kristoffer, Tang, Ka-Wei, Bernson, Elin, Thorén, Fredrik B
Publicado 2023